Skip to main content

4576 · D.Western Therapeutics Institute, Inc. · Financials

51 JPY +1 (+2.00%) At close · Nov 11
Market Cap
2.94B JPY
Shares
57.59M
Volume · Nov 11 190.9K Avg daily vol (3M) 346.37K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
387.62M -17.8%
FY2025 Revenue FY2021–FY2025
Net Income
-632.09M +51%
FY2025 Net Income FY2021–FY2025
Gross Margin
89.97% -0.1pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-159.92% +96.6pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-493.79M +62%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 387.62M 471.58M 428.36M 448.1M 414.42M
JPY 38.86M 46.84M 36.67M 27.57M 20.1M
JPY 348.76M 424.74M 391.7M 420.53M 394.32M
JPY -619.87M -1.21B -798.56M -305.91M -171.65M
JPY -630.49M -1.29B -826.8M -440.27M -159.71M
JPY 1.6M 1.6M 1.6M 1.6M 1.6M
JPY -632.09M -1.29B -812.41M -429.69M -149M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.